Leukemia: CLL - Chronic Lymphocytic Leukemia: A combination treatment of fludarabine, cyclophosphamide, and rituximab shows significant better results in time to disease progression and survival in Hodgkin and non-CLL - Chronic Lymphocytic Leukemia. Article updated August 16, 2011

  • CLL = chronic lymphocytic leukemia: A combination treatment of fludarabine, cyclophosphamide, and rituximab shows significant better results in time to disease progression and survival in Hodgkin and non-CLL = chronic lymphocytic leukemia. Article posted May 26, 2006